Health
T cells target broad range of SARS-CoV-2 epitopes, study shows – Drug Target Review
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
Posted: 29 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
A new study has suggested that T cells combat SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the virus’s Spike (S) protein. By attacking the coronavirus from many angles, the body can potentially recognise different SARS-CoV-2 variants. The study was led by scientists…
-
Noosa News22 hours agoBrisbane news LIVE updates: Queensland Police Commissioner Steve Gollschewski back on job after cancer treatment | Thief steals and crashes hearse
-
General21 hours agoStewards placed hundreds of bets on Tasmanian races, integrity investigation finds
-
Noosa News22 hours agoBega sells peanut processing plants at Kingaroy and Tolga to family business
-
Noosa News22 hours agoQueensland barramundi producer found guilty of environmental breaches